Back to Journals » Blood and Lymphatic Cancer: Targets and Therapy » Volume 11

ESCI
Impact Factor

Blood and Lymphatic Cancer: Targets and Therapy

ISSN: 1179-9889


       

Archive: Volume 11, 2021

Case report

Successful Non-Transplant Treatment of Double Hit Richter Transformation with Long-Term Remission

Seegobin K, Alhaj Moustafa M, Jiang L, Tun HW

Blood and Lymphatic Cancer: Targets and Therapy 2021, 11:67-72

Published Date: 22 September 2021

Review

Recent Advances in the Management of Patients with Relapsed/Refractory Follicular Lymphoma

Pongas G, Cheson B

Blood and Lymphatic Cancer: Targets and Therapy 2021, 11:55-66

Published Date: 30 July 2021

Review

Efficacy and Safety Profile of Ivosidenib in the Management of Patients with Acute Myeloid Leukemia (AML): An Update on the Emerging Evidence

Stemer G, Rowe JM, Ofran Y

Blood and Lymphatic Cancer: Targets and Therapy 2021, 11:41-54

Published Date: 22 June 2021

Review

Clinical Utility of Pegaspargase in Children, Adolescents and Young Adult Patients with Acute Lymphoblastic Leukemia: A Review

Bender C, Maese L, Carter-Febres M, Verma A

Blood and Lymphatic Cancer: Targets and Therapy 2021, 11:25-40

Published Date: 19 April 2021

Review

BCL2 Family Inhibitors in the Biology and Treatment of Multiple Myeloma

Gupta VA, Ackley J, Kaufman JL, Boise LH

Blood and Lymphatic Cancer: Targets and Therapy 2021, 11:11-24

Published Date: 12 March 2021

Original Research

The Impact of Obesity on the Outcomes of Adult Patients with Acute Lymphoblastic Leukemia – A Single Center Retrospective Study

Liu Q, Major B, Le-Rademacher J, Al-Kali AA, Alkhateeb H, Begna K, Elliott MA, Gangat N, Hogan WJ, Hook CC, Kaufmann SH, Pardanani A, Patnaik MS, Tefferi A, Wolanskyj-Spinner AP, Wei W, Litzow MR

Blood and Lymphatic Cancer: Targets and Therapy 2021, 11:1-9

Published Date: 22 January 2021